An overview on Estrogen receptors signaling and its ligands in breast cancer

被引:45
作者
Khan, Muhammad Zafar Irshad [1 ]
Uzair, Muhammad [2 ]
Nazli, Adila [3 ]
Chen, Jian-Zhong [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China
[2] Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China
[3] Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Islamabad 45320, Pakistan
关键词
Estrogen receptors; Breast cancer; Estrogen pathways; ER ligands; PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; TRANSCRIPTIONAL ACTIVATION; ER-ALPHA; AROMATASE INHIBITORS; MESSENGER-RNA; IN-VIVO; CELL-PROLIFERATION; HORMONE RECEPTORS; STEROID-RECEPTORS;
D O I
10.1016/j.ejmech.2022.114658
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Estrogen governs the regulations of various pathological and physiological actions throughout the body in both males and females. Generally, 17 beta-estradiol an endogenous estrogen is responsible for different health problems in pre and postmenopausal women. The major activities of endogenous estrogen are executed by nuclear es-trogen receptors (ERs) ER alpha and ER beta while non-genomic cytoplasmic pathways also govern cell growth and apoptosis. Estrogen accomplished a fundamental role in the formation and progression of breast cancer. In this review, we have hyphenated different studies regarding ERs and a thorough and detailed study of estrogen re-ceptors is presented. This review highlights different aspects of estrogens ranging from receptor types, their isoforms, structures, signaling pathways of ER alpha, ER beta and GPER along with their crystal structures, pathological roles of ER, ER ligands, and therapeutic strategies to overcome the resistance.
引用
收藏
页数:18
相关论文
共 211 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   Molecular structural characteristics of estrogen receptor modulators as determinants of estrogen receptor selectivity [J].
Agatonovic-Kustrin, S. ;
Turner, J. V. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (09) :943-951
[3]   Review of estrone sulfatase and its inhibitors - An important new target against hormone dependent breast cancer [J].
Ahmed, S ;
Owen, CP ;
James, K ;
Sampson, L ;
Patel, CK .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) :263-273
[4]   17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration [J].
Aka, Juliette A. ;
Zerradi, Mouna ;
Houle, Francois ;
Huot, Jacques ;
Lin, Sheng-Xiang .
BREAST CANCER RESEARCH, 2012, 14 (03)
[5]   G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells [J].
Albanito, Lidia ;
Madeo, Antonio ;
Lappano, Rosamaria ;
Vivacqua, Adele ;
Rago, Vittoria ;
Carpino, Amalia ;
Oprea, Tudor I. ;
Prossnitz, Eric R. ;
Musti, Anna Maria ;
Ando, Sebastiano ;
Maggiolini, Marcello .
CANCER RESEARCH, 2007, 67 (04) :1859-1866
[6]   Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts [J].
Alexander, Stephen P. H. ;
Mathie, Alistair ;
Peters, John A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 :S1-+
[7]  
[Anonymous], 2014, New J Sci
[8]   G Protein-Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses Toward Understanding of Its Activation Mechanism: A Comparative Homology Modeling Approach [J].
Arnatt, Christopher K. ;
Zhang, Yan .
MOLECULAR INFORMATICS, 2013, 32 (07) :647-658
[9]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[10]   The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells [J].
Bartella, Viviana ;
De Francesco, Ernestina Marianna ;
Perri, Maria Grazia ;
Curcio, Rosita ;
Dolce, Vincenza ;
Maggiolini, Marcello ;
Vivacqua, Adele .
CELLULAR SIGNALLING, 2016, 28 (02) :61-71